Thus, IAP’s pro-oncogenic activity could be enhanced by the loss of its bound LKB1 in LKB1 mutant cancer, while JAK1 could be directly weakened by IAP interaction, leading to STING suppression and immune resistance. This evidence concerns the gene JAK1 and cancer.